THERAVANCE BIOPHARMA, INC.
TBPH · NASDAQ
Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. Its research is focused in the areas of inflammation and immunology.
Market Data
Price
$14.03
+0.03 (+0.21%)
Market Cap$714M
P/E Ratio24.33
EPS$—
52W High$21.03
52W Low$7.90
Beta0.17
Data from Finnhub · Updated Mar 11, 2026